Recurrence of hepatitis-associated aplastic anemia after a 10-year Interval

Internal Medicine

Volumn 47, Issue 19, 2008, Pages 1733-1737

  Muta, Tsuyoshi ^a   Tanaka, Yoshinori ^a   Takeshita, Eiji ^a   Kobayashi, Yuichi ^a   Tokuyama, Takahito ^a   Ueda, Yoko ^a   Joko, Koji ^a   Fujisaki, Tomoaki ^a   Yokota, Eisuke ^a  

^a MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Cyclosporine antithymocyte globulin; Hepatitis associated aplastic anemia

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; LYMPHOGLOBULINE; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BLOOD EXAMINATION; BONE MARROW APLASIA; CASE REPORT; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; FATIGUE; FOLLOW UP; HEPATITIS ASSOCIATED APLASTIC ANEMIA; HEPATITIS NON A NON B NON C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; MALE; NAUSEA; OUTCOME ASSESSMENT; PROGNOSIS; RECURRENT INFECTION; REMISSION; TREATMENT DURATION;

ADOLESCENT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; HEPATITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; RECURRENCE; TIME FACTORS;

EID: 56349167024     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0933     Document Type: Article

References (24)

1. Brown KE, Tisdale J, Barrett J, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med 336: 1059-1064, 1997.
2. Pikis A, Kavaliotis J, Manios S. Incidence of aplastic anaemia in viral hepatitis in children. Scand J Infect Dis 20: 109-110, 1988.
3. Bhattacharyya M, Oakervee H, Dalley C, Glynn M, Cavenagh J. Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin. Clin Lab Haematol 27: 331-333, 2005.
4. Osugi Y, Yagasaki H, Sako M, et al. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. Haematologica 92: 1687-1690, 2007.
5. Teramura M, Kimura A, Iwase S, et al. Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults; a multicenter randomized study in Japan. Blood 110: 1756-1761, 2007.
6. Ishiyama K, Chuhjo T, Wang H, Yachie A, Omine M, Nakao S. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood 102: 1211-1216, 2003.
7. Honkaniemi E, Gustafsson B, Fischler B, Nemeth A, Frost BM, Papadogiannakis N, Winiarski J. Acquired aplastic anaemia in seven children with severe hepatitis with or without liver failure. Acta Paediatr 96: 1660-1660, 2007.
8. Pardi DS, Romero Y, Mertz LE, Douglas DD. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol 93: 468-470, 1998.
9. Miyamoto M, Takahashi H, Sakata I, Adachi Y. Hepatitis-associated aplastic anemia and transfusion-transmitted virus infection. Intern Med 39: 1068-1070, 2000.
10. Safadi R, Or R, Ilan Y, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant 27: 183-190, 2001.
11. Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 364: 355-364, 2004.
12. Dufour C, Corcione A, Svahn J, Haupt R, Battilana N, Pistoia V. Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia. Br J Haematol 115: 1023-1031, 2001.
13. Solomou EE, Keyvanfar K, Young NS. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood 107: 3983-3991, 2006.
14. Foon KA, Mitsuyasu RT, Schroff RW, McIntyre RE, Champlin R, Gale RP. Immunologic defects in young male patients with hepatitis-associated aplastic anemia. Ann Intern Med 100: 657-662, 1984.
15. Rosenberg YJ, Cafaro A, Brennan T, et al. Virus-induced cytokines regulate circulation lymphocyte levels during primary SIV infections. Intern Immunol 9: 703-712, 1997.
16. Bowen DG, Warren A, Davis T, et al. Cytokine-dependent by-stander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells. Gastroenterology 123: 1252-1264, 2002.
17. Roth E, Pircher H. IFN-gamma promotes Fas ligand- and perform-mediated liver cell destruction by cytotoxic CD8 T cells. J. Immunol 172: 1588-1594, 2004.
18. Matsunawa M, Kawakami K, Hisatake J, et al. Hepatitis-associated aplastic anemia preceded by a hemophagocytic syndrome-like state. Rinsho Ketsueki 44: 1010-1014, 2003 (in Japanese).
19. Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE. Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 103: 4588-4593, 2004.
20. Sugimori C, Yamazaki H, Feng X, et al. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia. Exp Hematol 35: 13-20, 2007.
21. Ito M, Kojima T, Miyata M, et al. Primary biliary cirrhosis (PBC)-CREST (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly and telangiectasia) overlap syndrome complicated by Sjögren's syndrome and arthritis. Intern Med 34: 451-454, 1995.
22. Nakamura T, Higashi S, Tomoda K, Tsukano M, Sugi K. Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjögren's syndrome and thyroid dysfunction. Clin Rheumatol 26: 596-600, 2007.
23. Marsh J, Schrezenmeier H, Marin P, et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93: 2191-2195, 1999.
24. Scheinberg P, Nuenz O, Young NS. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with repalsed or refractory severe aplastic anemia. Br J Haematol 133: 622-627, 2006.